article
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Experimental Neurology · 2000 · Vol. 166(1) · pp. 127–135
David W. Howells✉(Austin Health)Michelle J. Porritt(University of Melbourne)J Wong(University of Melbourne)Peter Batchelor(University of Melbourne)R. Kalnins(Heidelberg Repatriation Hospital)Abbey J. Hughes(Heidelberg Repatriation Hospital)Geoffrey A. Donnan(University of Melbourne)
Nerve injury and regenerationParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neural EngineeringPars compactaSubstantia nigraDopaminergicNeurotrophic factorsEndocrinologyBrain-derived neurotrophic factorInternal medicineBiologyNeuroscienceVentral tegmental area
MeSH terms
AgedAged, 80 and overDopamineHumansMiddle AgedNerve DegenerationNeuronsParkinson DiseaseRNA, MessengerSubstantia NigraIn Situ HybridizationBrain-Derived Neurotrophic Factor
Citations
503
FWCI
1.46
field-weighted impact
References
47
Percentile
80%
vs. same field & year
Citations per year
Cited by
The impact of age, weight and gender on BDNF levels in human platelets and plasma
Neurobiology of Aging · 2004 · 828 citations
Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease
Journal of Neurology · 2009 · 289 citations
References
Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Journal of the Neurological Sciences · 1973 · 2,649 citations
What features improve the accuracy of clinical diagnosis in Parkinson's disease
Neurology · 1992 · 1,302 citations
Related articles
The substantia nigra of the human brain
Brain · 1999 · 1,747 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.